Summary. The presence of a 'new' inherited substance has been detected in Caucasian, Bantu, and Chinese saliva samples, meconium, and gastric juice using the haemagglutinins of Clostridium botulinum, types C and D. It is serologically independent of ABH, Lewis, and Sda secretor status; at present it does not appear to be related to blood group systems and it is absent from the saliva of 7414% ofthe Caucasian population. The structure of the substance may be related in some way to human gangliosides. 
secretions has been known for some time (for a review see Race and Sanger, 1968) . More recent is the discovery of the antigen SdO in the saliva of Sd(a +) people (Macvie, Morton, and Pickles, 1967; Renton et al, 1967) . These substances were so named because the corresponding antigens were first detected on erythrocytes.
Blood group specific lectins and protectins (for a recent review see Sharon and Lis, 1972) have proved of considerable value in the determination of the immunodominant sugars responsible for blood group activity, since they are specifically inhibited by monosaccharides, whereas human or animal antibodies are complementary to larger determinants. Gold and Phelps (1972) have broadened the concept of lectins and protectins to include non-antibody haemagglutinins present in a wide range of organisms: viruses, bacteria, fungi, plants, sponges, snails and fishes, and have suggested the descriptive term 'receptor specific proteins' (RSP) for these substances.
During work with bacterial haemagglutinins from Clostridium botulinum types A, C, and D Balding et al (1973) found that while many saliva samples inhibit type C or type D in haemagglutination-inhibition tests, a few did not. This finding prompted us to determine whether the active in- hibiting substance was related to ABH, Lewis, or Sd" secretor status, and if not, whether it was inherited. The results of this investigation are reported here.
Materials and Methods
The Clostridium botulinum haemagglutinins used here have been described by Balding et al (1973) .
Anti-H lectin was prepared from Ulex europaeus seeds as described by Dunsford and Bowley (1967) .
Human red cells and saliva, except as detailed otherwise below, were obtained from the Regional Transfustion Centre, Bristol. Red cells with the following rare phenotypes were a gift from Dr R. R. Race It is possible that there may be not one but two new substances detected by type C and type D, respectively, as suggested by the saliva inhibition titres; we have not, however, been able to confirm identity, partial identity, nor non-identity of their receptors in agar gel diffusion tests, as neither type C nor type D appear to form a precipitate with a soluble receptor substance.
The inhibiting substance is present in Caucasian, Bantu, and Chinese salivas. In Fig. 1 , the graphs show the number of salivas giving a particular inhibition titre with type C against that inhibition titre. Fig. 1 shows the results with unrelated Caucasians and unrelated Bantus; the level of secretion appears to be less in the latter group. The bimodal distribution of titres is probably due to differences in zygosity; the peak for higher inhibition titres corresponds to homozygotes ( of twins have also been tested; on the basis of our results one pair appears to be monozygotic, the other pair dizygotic.
Results of type C H/I tests with other substances are shown in Table II . The three meconium samples and the gastric juice samples contain the inhibiting substance. One neutralized gastric juice sample was tested to see if boiling (to inactivate enzymes) affected the inhibitor; both the boiled and unboiled samples inhibited haemagglutination.
It has been found (Balding et al, 1973) that the structure or configuration of the receptor for type C and type D probably depends on the presence of N-acetyl-neuraminic acid (NANA); three specimens of ABH blood group specific glycoproteins with varying quantities of sialic acid were therefore tested. None significantly inhibited type C, again showing that the substance inhibiting type C is independent of the ABH active glycoproteins irrespective of their sialic acid content. H/I tests with salivas of 10 Caucasian families were performed with type C (Table III) . One of these families, family B, proved very interesting and was also investigated with type D and with anti-H lectin; results are shown in Table IV . In this family the father is heterozygous for the gene controlling secretion of the inhibiting substance. The saliva sample from the mother gave complete lack of inhibition. Results with the saliva of the children strongly suggest that the inhibiting substance is a dominant inherited character. Discussion The discovery of an inherited blood group active substance secreted in saliva has previously followed discovery of the associated red cell blood group, primarily because the corresponding antibody is first detected and investigated; saliva samples are then used in H/I tests with the antibody leading in a few cases to the recognition of a secreted soluble antigenic substance. The results of such studies have proved valid even though most of the precautions described by Sturgeon et al (1973a and b) to minimize variables governing secretion of saliva glycoproteins have not been taken. The same is true of routine tests for detection of ABH secretors. The large titre differences observed in our tests and in family studies therefore reflect real differences in salivary secretor status which, as shown by the results with family B, are inherited as dominant characteristics. It is however conceivable, but is thought unlikely, that the titre differences are not due to zygosity but to quantitative alleles (Sturgeon and Arcilla, 1970) .
In this report we describe a 'new' substance secreted in saliva recognized by using, not an antibody, but a RSP. Should no human red cell be found which fails to be agglutinated by type C or type D, the concept of an inherited 'saliva group' not related to a red cell group must be accepted.
Inhibition studies using purified human gangliosides (our unpublished observations) indicate that preferentially ganglioside GI (Klenk and Gielen, 1963; Kuhn and Weigandt, 1963a ) may be the receptor for type C, and ganglioside GIV (Kuhn and Weigandt, 1963b) may be the receptor for type D on human red cells.
It has been shown that ABH antigens are glycoproteins in secretions, but may be glycolipids* on red cells. In the same way, the substance in saliva inhibiting type C and type D may be glycoprotein with a sugar chain similar to the inhibiting ganglioside, which may be the glycolipid receptor on red cells. The exact structure of the inhibiting saliva substances must await results of purification from saliva.
The presence of blood group active substances in secretions, especially saliva, has proved both genetically and biochemically important. The * ABH antigens on red cells may also be glycoproteins.
substances inhibiting H by type C and type D are also found in secretions. Like the ABH substances, they may prove of interest in the study of cancer of the gastrointestinal tract, and in population studies of various races.
The finding of the inherited saliva substance reported here provokes the idea that other non-blood group specific RSP may also react with as yet undefined inherited substances in secretions.
We thank all those who generously donated materials used in this investigation. We are very grateful to Dr R. R. Race and Dr R. Sanger for helpful suggestions. The work was supported by a grant from the British Empire Cancer Campaign for Research.
